CEO of shuttered biotech Magenta Therapeutics makes leap to Flagship startup


The former CEO of a biotech that shut down after a patient death in a clinical trial has made his way to a new startup backed by Flagship Pioneering.

Previous Behind the deal: How MCM CPAs & Advisors fit into Cherry Bekaert's growth plan
Next CBJ Buzz: Mexican restaurant The Matador coming to South End; Demolition of Uptown Cabaret begins